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Accumulating evidence shows that periostin, a matricellular protein, is involved in many fundamental biological
processes such as cell proliferation, cell invasion, and angiogenesis. Changes in periostin expression are commonly
detected in various cancers and pre-cancerous conditions, and periostin may be involved in regulating a diverse set
of cancer cell activities that contribute to tumorigenesis, cancer progression, and metastasis. Periostin has also been
shown to be involved in many aspects of allergic inflammation, such as eosinophil recruitment, airway remodeling,
development of a Th2 phenotype, and increased expression of inflammatory mediators. In an in vivo model,
bronchoalveolar lavage (BAL) fluid obtained from ovalbumin-challenged mice was found to contain significantly
higher levels of periostin compared to BAL samples from control mice. To date, the molecular mechanisms
involving periostin in relation to asthma in humans have not been fully elucidated. This review will focus on what is
known about periostin and its role in the pathophysiological mechanisms that mediate asthma in order to evaluate
the potential for periostin to serve as a biomarker and therapeutic target for the detection and treatment of asthma,
respectively.
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Periostin, also referred to as osteoblast-specific factor2,
was first described in 1993 and was named based on its
expression in the periodontal ligament and periosteum
of adult mice [1]. Subsequent studies demonstrated that
periostin is ubiquitously expressed in a wide variety of
normal adult tissues and fetal tissues, including embry-
onic periosteum, periodontal ligament, placenta, cardiac
valve, adrenal gland, lung, thyroid tissues [2].
Periostin is a 90-kDa member of the fasciclin-containing
protein family and is encoded by the POSTN gene in
humans (GenBank accession no., D13664). Periostin is a
matricellular protein that mediates cell activation by bind-
ing to receptors present on the cell surface [3–5]. Perios-
tin is a secreted protein that shares structural homology
with the axon guidance protein, FAS1, in insects [6]. In
addition, periostin is highly homologous with transform-
ing growth factor (TGF)-β-induced protein, βig-h3,which
promotes cell adhesion, the development of cardiac valves
[7], and the spreading of fibroblast [8], epithelial [9], and* Correspondence: doctorzhangj@sina.com
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unless otherwise stated.ovarian cells [10]. Periostin is expressed at higher levels in
patients affected by conditions that are associated with in-
creased cell division, cell turnover, cell invasion, and
angiogenesis [11].
More recently, periostin has been recognized as having
important roles in the development of bone, tooth, and
heart valves, as well as during the healing process after
myocardial infarction and in the development of various
tumors [12]. Furthermore, periostin has been implicated
in atopic conditions such as dermatitis [13] and rhinitis/
rhinosinusitis [14]. In allergic skin inflammations, peri-
ostin induction after an initial injury contributes to the
establishment of sustained chronic inflammation and tis-
sue remodeling [15]. Chronic rhinosinusitis inflamma-
tion is mediated by periostin and osteopontin, and these
proteins induce a proliferative response within the extra-
cellular matrix (ECM) framework which leads to large
scale remodeling of sinus histopathology [14]. Increased
expression of periostin in tissues has also been associ-
ated with several inflammatory conditions that have
been investigated in the fields of eosinophilia (e.g., otitis
media, eosinophilic esophagitis), ophthalmology (e.g.,
proliferative diabetic retinopathy), hematology (e.g., boneis an Open Access article distributed under the terms of the Creative Commons
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globulin (Ig)G4-related sclerosing sialadenitis and sclero-
derma) [5].
The role of periostin in asthma and type 2 inflamma-
tory responses is an area of active research. Recently,
Sehra et al. and Gordon et al. demonstrated that perios-
tin protects mice from allergic airway inflammation,
whereas Blanchard et al. showed that periostin acceler-
ates allergen-induced eosinophil recruitment in the lung
and esophagus [16–18]. A similar protocol using intra-
nasal administration of Aspergillus fumigatus (A. fumiga-
tus) led to different outcomes, thereby suggesting that
the role of periostin in allergic airway inflammation re-
mains unclear [15].
A newly proposed approach to asthma classification is
based on “endotypes” that represent specific cellular pat-
terns. In combination with clinical characteristics, it is
proposed that these endotypes can establish patient sub-
groups. Correspondingly, an analysis of induced sputum
samples allowed inflammatory phenotypes to be deter-
mined according to granulocytic composition, namely
eosinophilic, neutrophilic, mixed granulocytic, or pauci-
granulocytic [19].
In recent decades, the number of studies involving
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Periostin has been found to be related to the physiopa-
thology of multiple diseases such as: ankylosing spondyl-
itis (AS) [20], idiopathic interstitial pneumonias (IIPs)
[21], idiopathic pulmonary fibrosis (IPF) [22], renal in-
flammation and fibrosis [23], heart aging [12], cancer
[24, 25], and allergic diseases (Table 1). Periostin is in-
volved in many aspects of asthma as well, including eo-
sinophil recruitment [12], airway remodeling, development
of a Th2 phenotype, and contributes to the increased ex-
pression of inflammatory mediators [26, 27]. This review
will focus on what is known about periostin and its role in
the pathophysiological mechanisms that mediate asthma.Periostin in inflammation
Asthma is a chronic inflammatory respiratory disease
that is commonly characterized by airway inflammation,
airway hyperresponsiveness (AHR), and/or reversible air-
way obstruction. To date, there are treatments available
that target eosinophilic inflammation in asthma, and
these have been able to reduce asthma exacerbations in
some cases [28]. However, the inflammatory mecha-
nisms leading to asthma symptoms and AHR in the ab-
sence of sputum eosinophilia are poorly understood.Comments
sinus tissue
< 0.001) and
Periostin levels positively correlate with radiologic
disease severity scores. Increased levels of periostin in







Reduced gene expression of periostin following
resolution of disease suggests that POSTN may
represent a pathogenesis indicator or biomarker of CRS
disease activity and responsiveness to treatment [74].
ith AD





Periostin may play a critical role in disease severity and






Serum periostin levels are significantly elevated in AERD





Periostin is a systemic biomarker of airway eosinophilia
in asthmatic patients and has the potential to be used
for patient selection for emerging asthma therapeutics
that target Th2 inflammation [36].
lymerase chain reaction, CRSsNP chronic rhinosinusitis without nasal polyps, FC
enzyme-linked immunosorbent assay, PV psoriasis vulgaris, TARC thymus and
thma
Li et al. Respiratory Research  (2015) 16:57 Page 3 of 10Periostin is potentially relevant in the pathogenesis of
asthma-associated inflammation and its phenotypes [29, 30].
Periostin expression in the inflammatory setting
A variety of tissues and cell types express periostin
under basal conditions, including epithelial cells, fibro-
blasts, and eosinophils [9, 31, 32]. However, the pattern
of expression can be modulated in response to inflam-
mation. For example, in mice exposed to house dust
mites (HDMs), periostin expression was found to in-
crease in the airway epithelium, subepithelium, smooth
muscle, and inflammatory cells, while mice that received
an injection of OC-20 (a neutralizing antibody to pe-
riostin) exhibited reduced airway responsiveness follow-
ing exposure to HDMs [26]. HDM exposure also
increased airway responsiveness in Postn+/+ mice and
not in Postn−/−mice [26]. For patients with atopic
dermatitis (AD), serum levels of periostin were signifi-
cantly higher than in patients with psoriasis vulgaris
(PV) and healthy controls [33]. Moreover, in work by
Covone et al. and Kanemitsu et al., periostin levels were
found to positively correlate with juvenile idiopathic arth-
ritis and asthma disease severity, respectively [34, 35]. In
addition, periostin levels positively correlated with thymus
and activ ation-regulated chemokine (TARC) levels, lac-
tate dehydrogenase (LDH) levels, and eosinophil counts,
yet not with IgE levels [33]. In asthma patients, gene ex-
pression of periostin in sputum cells and elevated serum
levels of periostin were detected by PCR and ELISA, re-
spectively [36, 37]. Periostin has also been shown to
promote inflammation in experimental models of allergic
disease, including models of HDM-induced atopic derma-
titis, ovalbumin (OVA)-induced allergic rhinitis, and A.
fumigatus-induced eosinophilices ophagitis [26].
In vitro assays have confirmed that expression of
POSTN and TWIST1 are elevated in fibroblast-like syno-
viocytes (FLSs) of rheumatoid arthritis patients (RA-FLSs)
and are crucial for the migration and invasion of FLSs
stimulated with interleukin (IL)-1β [38]. Moreover, regula-
tion of FLS migration by POSTN and TWIST1 was con-
firmed in an in vivo animal model of skin inflammation
[38]. These findings are consistent with the up-regulation
of periostin that is observed with immune activation, and
with the roles of dietary fat and IL-1β in innate immune
activation [28]. Furthermore, epithelial cells and fibro-
blasts in vitro produce large amounts of periostin, and
these are the major cell types that contain periostin [32].
Increased levels of periostin have also been detected in re-
lation to neutrophils, eosinophils, mast cells, monocytes,
and lymphocytes.
Regulation of leukocyte trafficking and activation
In studies of IPF, inflammation has been found to pre-
cede the onset of fibrosis. Moreover, when IPF wasinduced in wildtype and periostin-deficient mice with
administration of bleomycin (BLM), periostin-dependent
infiltration of neutrophils and macrophage were ob-
served, while accumulation of periostin was not detected
[12]. These results suggest that the basal concentration
of periostin present in lung tissue is sufficient for an
acute response, and it is possible that accumulated levels
of periostin may enhance or sustain IPF-associated in-
flammation [12]. Given that previous studies have dem-
onstrated that periostin also plays a critical role in the
trafficking, activation, and cytokine release of leukocytes
[39, 40], these findings suggest that periostin contributes
to esophagitis, and periostin may directly regulate
leukocyte (eosinophil) accumulation in T helper type 2-
associated mucosal inflammation in both mice and
humans [18].
Eosinophils
An increasing number of studies have confirmed that
plasma levels of periostin are higher in patients with eo-
sinophilic asthma [41, 42]. In mice, the numbers of eo-
sinophils tend to be lower in periostin-deficient mice
compared with wild-type mice, although the down-
regulation is not statistically significant [12]. A functional
role for periostin in eliciting esophageal eosinophilia has
been demonstrated using periostin-null mice, where
allergen-induced recruitment of eosinophils to the lung
and esophagus have been found to undergo a 66 and 72 %
decrease, respectively [18]. Periostin-null mice also re-
spond to lung challenges with significantly lower numbers
of eosinophils in the lung and higher numbers of eosino-
phils in blood, and they exhibit reduced inflammation in
an allergic skin inflammation model [5, 43]. To explain
why periostin levels increase with asthma, it has been hy-
pothesized that eosinophils secrete periostin [31]. How-
ever, other researchers have proposed that eosinophilic
asthma derives from the production of periostin mainly by
airway epithelial cells and fibroblasts [44–46]. However, if
eosinophils can secrete periostin, what regulates this pro-
duction? Periostin has been shown to act on eosinophils,
thereby enhancing their recruitment to lesions, and acts
on airway epithelial cells to induce TGF-β activation, as
part of the pathogenesis of bronchial asthma [12]. In
Figs. 1 and 2, the relationship between periostin and air-
way epithelial cells and fibroblasts is illustrated in relation
to Th2-type asthma and subepithelial fibrosis, respectively
[6, 9, 31, 32, 44–48]. In both mouse and human studies,
periostin appears to promote eosinophil recruitment, and
to enhance the specific adhesion of blood eosinophils that
are stimulated by IL-5 or the related cytokines, IL-3 and
granulocyte-macrophage colony-stimulating factor (GM-
CSF) [43]. Correspondingly, the intranasal inhalation of
allergens from A. fumigatus in a recent study of periostin-
deficient mice demonstrated that fewer eosinophils were
Fig. 1 Periostin is involved in the pathogenic process of eosinophils and Th2-type asthma. Briefly, allergens induce the secretion of IL-4 and IL-13
from certain immune cells, thereby stimulating eosinophils cells to produce periostin. Periostin, in turn through an autocrine pathway (indicated
by the green colored receptors), acts on eosinophils to stimulate the adhesion of purified human blood eosinophils, while also enhancing their
recruitment to an asthmatic airway. IL-5, IL-3, or GM-CSF can also stimulate the adhesion of purified human blood eosinophils, thereby leading to
a vicious cycle. Macrophage produce periostin, and this can enhance the secretion of matrix metalloproteinases (MMPs). Furthermore, in the
presence of histamine, expression of periostin by other cells is enhanced
Fig. 2 The role of periostin inthe pathogenic process of subepithelial fibrosis. Briefly, Th2-polarized inflammation leads to the recruitment of
various immune cells and these secrete IL-4 and IL-13 in combination with TGF-β to stimulate fibroblasts and epithelial cells to produce periostin.
Periostin, in turn through an autocrine pathway (indicated with green colored receptors), acts on fibroblasts and epithelial cells, thereby leading
to a vicious cycle. Additional functions of periostin include: the promotion of fibroblast differentiation into myofibroblasts, the induction of
fibroblast migration, and as a co-factor of TGF-β, periostin promotes ECM production and the differentiation of myofibroblasts. Periostin further
enhances fibrosis by binding to other ECM proteins (e.g., collagen I, fibronectin, and tenascin-C) and by inducing collagen fibrillogenesis. Adapted
from [27]
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blood eosinophilia [16]. Moreover, no significant differ-
ences in mucus production were detected. Additional
studies demonstrated that periostin, as a ligand for the
integrins, αvβ3, αvβ5, α4β6, and αMβ2 (CD11b), was able to
attract eosinophils via CD11b, and increased the adhesion
of eosinophils to fibronectin [26]. In vitro studies further
indicated that α4β1 and αMβ2 are the principal integrins
mediating eosinophil adhesion, particularly in relation to
vascular cell adhesion molecule-1 and the novel αMβ2 lig-
and, periostin [49]. In vivo, blood eosinophils express β1
integrins that have been characterized by intermediate ac-
tivity and intermediate conformations in studies per-
formed using monoclonal antibodies (mAbs) N29 and
KIM-127, respectively, potentially due to eosinophil bind-
ing of P-selectin on the surface of activated platelets and
exposure to low concentrations of IL-5, respectively [49].
In contrast, airway eosinophils recovered by bronchoalve-
olar lavage (BAL) after segmental antigen challenge ex-
press high-activity β1 and high-activity αMβ2 integrins that
do not require IL-5 [49].
Intense eosinophilic infiltration is closely related with
an elevated production of cytokines and chemokines
such as IL-5 and eotaxin [50]. For example, in an in vitro
model, periostin was adsorbed to polystyrene and adhe-
sion of purified human blood eosinophils stimulated by
IL-5, IL-3, or GM-CSF was supported. In contrast, the ad-
hesion of eosinophils treated with IL-4 or IL-13 was not
supported [43]. Furthermore, the degree of adhesion
achieved was found to depend on the concentration of
periostin present during the coating and activation by cy-
tokines during the adhesion assay. Interestingly, both full-
length periostin and a spliced version of periostin that
lacks the C-terminal exons, 17, 18, 19, and 21, have been
found to support adhesion. However, in the presence of
a monoclonal antibody raised against αM or β2 integrin
subunits, versus antibodies raised against other eosino-
phil integrin subunits, only the former inhibited adhe-
sion. Adsorbed periostin was also observed to support
αMβ2-dependent random motility of IL-5-stimulated
eosinophils, with optimal movement observed at an
intermediate coating concentration. In the presence of
IL-5, eosinophils adhere to periostin and form punctate
structures that express filamentous actin, gelsolin, and
phosphotyrosine. This profile is consistent with that
observed for podosomes, which represent highly dy-
namic adhesive contacts that are distinct from classical
focal adhesions. In work by Johansson et al., αMβ2
(CD11b/CD18, Mac-1) was identified as an adhesive
and promigratory periostin receptor that is expressed
by cytokine-stimulated eosinophils. Thus, periostin may
function as a haptotactic stimulus to guide eosinophils
to asthmatic airways where high levels of periostin are
present [43]. Deposition of periostin in airways as aresult of Th2 immunity may also promote eosinophil
recruitment and serve as a guide for eosinophil migra-
tion in the ECM of asthmatic airways. Correspondingly,
it is possible that a periostin gradient may complement
the gradients of the chemotactic agents that eosinophils
are exposed to, thereby leading to the arrest of cells at
a critical density of periostin. Furthermore, interactions
with periostin may also affect eosinophil survival and
mediator release, and this may provide an opportunity
to modulate allergic inflammation and airway remodel-
ing [43]. IL-4, IL-13, and TGF-β are major triggers of
periostin production [51]. Thus, while IL-5, IL-3, and
GM-CSF have the capacity to stimulate the adhesion of
purified human blood eosinophils, IL-4 and IL-13 may
trigger periostin production. Further experiments are
needed to investigate these possibilities, although an
autocrine loop involving periostin and eosinophils
could lead to a vicious cycle of signaling.
Cell classification, especially in relation to levels of
periostin, may have important significance for cases of
eosinophil asthma. In a study of periostin concentration
in sputum by Bobolea et al., periostin concentration and
numbers of eosinophils were found to be closely related
[29]. However, in another study, serum levels of perios-
tin did not distinguish eosinophilic airway inflammation
from non-eosinophilic airway inflammation [52]. There-
fore, additional experiments need to be performed to in-
vestigate whether periosteum has a differential role in
various asthma cell types.
Macrophage
In vivo, the infiltration of macrophage in BAL fluid is
significantly reduced in periostin-deficient mice com-
pared with wild-type mice [12]. Thus, periostin may
serve as a chemoattractant and adhesion factor to affect
the trafficking of macrophage. In vitro studies have
showed that M2-polarized macrophage significantly
increases mRNA levels of periostin, and this induc-
tion may promote retinal neovascularization and fibrosis
[53, 54]. In vivo, immunohistochemistry assays have de-
tected weak expression of periostin in reactive astrocytes
in the periinfarct region and in microglia/macrophage in
infarct regions on days 3 and 7 post-infarct, respectively
[55]. Furthermore, both in vitro and ex vivo studies have
revealed that periostin promotes tube formation and the
mobilization of endothelial cells (ECs), and prominently
increases matrix metalloproteinase secretion from cul-
tured valvular interstitial cells, ECs, and macrophage in
a cell type-specific manner [56]. Thus, macrophage have
many important roles in processes such as cell prolifera-
tion and cell remodeling, in airway hyperresponsiveness
and corticosteroid resistance, and in asthma exacerba-
tions and airway remodeling [57]. It is also hypothesized
that pulmonary macrophage produce periostin through
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to the pathogenesis of asthma. Correspondingly, investiga-
tions of the mechanisms that mediate the function and
regulation of macrophage are ongoing and are of great
interest in the field of asthma research, even in studies of
asthmatic inflammation. Furthermore, accumulating evi-
dence suggests that cell type is a key consideration for the
treatment of asthma, and it has extraordinary significance.
Neutrophils
Periostin provides a cell-binding matrix which can facili-
tate the infiltration of inflammatory cells in the airways
[26]. It has been observed that neutrophils are the first
cells recruited to the site of an allergic reaction, and
thus, neutrophils may influence clinical presentation.
Correspondingly, neutrophils have been linked to the de-
velopment of severe chronic asthma, as well as sudden
severe attacks of asthma [58].
Inflammation induces the expression of TGF-β and/or
IL-4 and IL-13 in macrophage and neutrophils, leading to
the expression of periostin and other ECM molecules such
as fibronectin and tenascin-C in fibroblasts [59]. Periostin
can attract neutrophils and other inflammatory cells to
the airway, similar to eosinophils. However, neutrophils
can also promote the release of periostin through the se-
cretion of cytokines. When Bentley et al. examined the ef-
fects of periostin deficiency on inflammatory cells in BAL
fluid and in lung tissue, exposure to HDMs increased
neutrophil, macrophage/monocyte, lymphocyte, and eo-
sinophil numbers in BAL fluid samples from Postn+/+
mice, while Postn−/− mice exposed to HDMs had fewer
lung Grl+ neutrophils, TCR-β+ T cells, and Grl+ and
Siglec-F+ eosinophils [26]. Immunohistochemical stainings
also showed that HDM exposure increased periostin ex-
pression in the airway epithelium, subepithelium, and in-
flammatory cell infiltrates, while periostin expression was
absent in Postn−/− mice [26]. Uchida et al. previously dem-
onstrated that periostin is able to synergistically induce
the production of several chemokines and cytokines in re-
sponse to TNF-α and IL-1β [12]. Similarly, the present
findings suggest that both TNF-α and periostin are re-
quired for the maximal production of chemokines. How-
ever, in the former study [12], it was also reported that in
the absence of periostin, Ccl4 and IL-1 were not induced
by TNF-α, and IL-1 signaling was required, and was suffi-
cient on its own, to mediate BLM-induced pulmonary in-
flammation and fibrosis. It was further demonstrated that
activation of extracellular signal-regulated kinases 1 and 2
(ERK1/2), as well as phosphatidylinositol 3-kinase (PI3K),
is important for TNF-α-mediated activation of NF-κB and
activator protein-1 [12]. Correspondingly, the authors hy-
pothesized that periostin may enhance TNF-α signaling
via ERK1/2 and PI3K. Accumulating evidence also sug-
gests that IL-1β may play an important role in thepathogenesis of asthma [60]. It is possible that periostin
can further lead to a malignant role for asthma since peri-
ostin can enhance the production of IL-1. In a study by
Hayashi et al., nasal administration of OVA and IL-18 was
found to act on memory type T helper (Th)-1 cells to in-
duce AHR and inflammation characterized by peribron-
chial infiltration by neutrophils and eosinophils [61].
These Th1 cells were also found to secrete several types of
cytokines, including IFN-γ and the bronchogenic cytokine,
IL-13, when stimulated with antigen (Ag) and IL-18.
Neutralization of IL-13 during the Ag plus IL-18 challenges
inhibited eosinophilic infiltration, lung fibrosis, and periostin
deposition; while neutralization of IFN-γ during the Ag plus
IL-18 challenges inhibited neutrophilic infiltration and AHR
[61]. Thus, periostin appears to coordinate with both eosino-
phils and neutrophils, although the mechanisms involved re-
main to be fully characterized. It is possible that periostin
may serve as a marker of cell classification and/or a thera-
peutic target for the treatment of asthma, and additional
studies are needed to investigate these possibilities.
Other cells
Dendritic cells (DCs)
In a very recent study, Bentley et al. reported that lower
levels of IgE were detected following the treatment of
periostin-depleted mice with OC-20. Correspondingly,
the authors hypothesized that interactions between
CD11b+ DCs and periostin facilitate the activation of T
cells and Th2 differentiation [26]. CD11bhigh DCs were
also found to mediate CD4+ Th2 responses to OVA and
HDMs [26]. In the same study, DCs isolated from Postn−/−
mice exposed to HDMs did not express CD86 [62]. Bind-
ing of CD86 by CD28 normally provides CD4+ T cells with
a costimulatory signal that decreases their activation
threshold and enhances their activation [26]. When splenic
T cells were incubated with the same DCs isolated from
Postn−/− mice, or with DCs treated with OC-20, deficient
HDM-induced IL-13 responses were observed compared
with T cells incubated with wild-type or IgM-treated DCs.
Furthermore, bone marrow-derived DCs from wildtype
mice were sufficient to promote allergic responses in peri-
ostin knockout mice exposed to HDMs. Lastly, in vitro,
periostin has been shown to activate nuclear factor (NF)-κB
in keratinocytes, consistent with a role for NF-kB in DC ac-
tivation [26]. Taken together, these results suggest that peri-
ostin is required for maximal DC activation.
Goblet cells
In Postn−/− lungs versus Postn+/+ lungs, increased airway
resistance and significantly enhanced mucus production
by goblet cells is observed, concomitant with increased
expression of Gob5, a putative calcium-activated chlor-
ide channel involved in the regulation of mucus produc-
tion, and Muc5ac [16]. Correspondingly, in wild-type
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sion of Gob5 in primary murine airway epithelial cells
[16]. Periostin may also bind integrins α4 and β1/2,
which have roles in mediating asthma, thereby trig-
gering intracellular signaling pathways that repress
mucus-inducing transcription factors such as NF-κB,
Sp1, and AP-1 [63]. Data reported by Sehra et al.
demonstrate that in the absence of periostin, in-
creased differentiation of epithelial cells into mucus-
producing goblet cells occurs, thereby suggesting that
periostin contributes to the homeostasis of goblet cell
metaplasia (GCM) during allergic inflammation [16].
Periostin can also reduce the symptoms associated
with asthma.Mast cells
Human mast cells express functional receptors for IL-3,
IL-5, and GM-CSF. In the presence of stem cell factor
(SCF), IL-3 has been shown to enhance mast cell growth
by decreasing levels of mast cell apoptosis [64]. Corres-
pondingly, loss of periostin appears to enhance the forma-
tion of polyp-like lesions and the infiltration of mast cells
in a mouse model of eosinophilic rhinosinusitis with nasal
polyps [65]. Furthermore, histamine has been found to
directly induce periostin expression in a dose-dependent
manner in wild-type fibroblasts, and induction of periostin
and collagen by histamine involves activation of the H1
receptor-mediated ERK1/2 pathway [66].T cells
Expression of periostin is induced in epithelial cells in
response to inflammatory cytokines, including signature
cytokines of type 2 immune responses, such as IL-4 and
IL-13 [16, 27]. Expression of periostin is also induced in
lung fibroblasts by the anti-inflammatory cytokine, TGF-
β [16, 27]. Some studies have shown that periostin-
deficient mice have increased serum levels of IgE and
peripheral Th2 responses, and also exhibit airway resist-
ance, mucus production, and decreased production of
lung TGF-β [43]. However, decreased mucous metapla-
sia and lower levels of IL-4 expression have also been re-
ported. The mechanism by which periostin negatively
affects allergen-induced responses may involve augmen-
tation of TGF-β-induced T regulatory cell differentiation
[17]. Correspondingly, a protective role for periostin and
TGF-β has been demonstrated in IgE-mediated allergies
and airway hyperresponsiveness [17]. Serum levels of
periostin have also been found to reflect local produc-
tion levels of periostin in inflamed lesions that are in-
duced by Th2-type immune responses, and these levels
have been used to predict the efficacy of Th2 antagonists
against bronchial asthma [4].Periostin in experimental models of asthma
The murine model of asthma treated with HDMs has
been extensively studied. In this model, Postn+/+ mice
have exhibited increased airway responsiveness [67], as
well as elevated levels of periostin expression in the air-
ways, not only in the peribronchial inflammatory cells, but
in the fluid lining of the airways as well [59]. Postn+/+ and
wild-type mice have also exhibited significantly elevated
levels of allergic airway inflammation, with an increased
number of eosinophils present compared with periostin-
deficient mice [5, 12, 26, 43]. In contrast, Postn−/− mice
have exhibited higher goblet cell metaplasia, higher serum
IgG E levels, and increased peripheral Th2 responses com-
pared to wild-type mice [16]. In addition, compared with
wild-type controls, periostin-deficient mice develop in-
creased AHR and serum IgE levels following allergen
challenge, while mucus metaplasia and peribronchial fi-
brosis remain unaffected [17]. Postn+/+ mice also manifest
significantly higher airway responsiveness to HDMs com-
pared to Postn−/− mice, and the transfer of bone marrow-
derived DCs from Postn+/+ mice is sufficient to promote
allergic responses in HDM-exposed Postn−/− mice [26]. In
a murine model of eosinophilic rhinosinusitis with
nasal polyps to OVA, Postn−/− mice exhibited enhanced
polyp-like lesion formation and mast cell infiltration [65].
Furthermore, in a murine model of allergic airway inflam-
mation, the sensitization and challenge of periostin-deficient
mice with OVA resulted in an increased peripheral Th2 re-
sponse compared with control mice [16].
Periostin in human asthma
The inflammatory response in asthma is heterogeneous
and involves many types of cells and cellular elements. It
is important to recognize the different inflammatory
phenotypes of asthma in order to understand the under-
lying disease processes. The different inflammatory phe-
notypes are also clinically relevant based on their potential
to differentiate responses to therapeutic interventions
[28]. Simpson et al. have classified asthmatic subjects into
four groups based on the presence of neutrophils and eo-
sinophils, with the 95th percentile from healthy control
subjects used as a cut-off point [68]. The four inflamma-
tory subtypes included: neutrophilic asthma, eosinophilic
asthma, mixed granulocytic asthma, and paucigranulocytic
asthma. In recent years, many studies have elucidated the
distinct mechanisms of these subgroups, and these have
corresponded with the differential responses to therapy
that have been observed. The mechanisms of eosino-
philic asthma involve activation of Th2 pathways, typic-
ally by an allergen, and the release of Th2 cytokines,
such as IL-4, −5, −9 and −13. Bronchial biopsies from
these patients have shown an infiltration of eosinophils,
activated mast cells, and T cells that are predominantly
Th2 cells [28].
Li et al. Respiratory Research  (2015) 16:57 Page 8 of 10It is hypothesized that periostin plays an important
role in eosinophilic forms of asthma [31]. In murine
models, periostin has been linked to more severe asthmatic
airway inflammation responses and hyperresponsive-
ness [26]. In humans, periostin has been found to pro-
long Th2/eosinophilic inflammation and to aggravate
airway remodeling [69, 70]. These effects have also
been associated with up-regulation of IL-4/13 [26, 27,
37, 66], and an increased number of eosinophils in the
airways [47, 71, 72]. Furthermore, levels of periostin re-
flect persistent eosinophilic airway inflammation in se-
vere asthmatics despite a high dose of ICS [31]. The
latter can be explained in the context of an inflamma-
tory phenotype which involves an increase in levels of
Th2 cytokines, increased asthma severity, atopy, late-
onset disease, and steroid refractoriness [19]. To date,
cases of human asthma have not been analyzed for
levels of periostin according to inflammatory pheno-
type. Furthermore, the available data have only demon-
strated that expression of periostin is higher at both the
gene and protein levels in asthmatic serum and sputum
samples [31, 47, 51, 69–71, 73]. More recently, how-
ever, a greater role for periostin has been identified in
relation to fibroblasts and airway epithelial cells in
models of asthma (Fig. 2), while fewer studies have ad-
dressed the relationship between periostin and other in-
flammatory cells. Therefore, it will be important to
elucidate the role of periostin in the mechanisms that
mediate the various asthma phenotypes.
Conclusion
Periostin is a multifunctional protein that is expressed
by a variety of inflammatory cells. In addition, over ex-
pression of periostin has been observed in various types
of disease concomitant with an increase in the number
of inflammatory cells present. Periostin was first charac-
terized as a matricellular protein, and since has been
well-characterized as an important regulator of inflam-
matory cell infiltration and activation. In the field of
asthma research, the role of periostin in relation to air-
way epithelial cells and fibroblasts has been of great
interest, as well as its role in the pathogenesis of asthma
caused by subcutaneous fibrosis. This perplexing para-
dox may be explained by considering the heterogeneity
of airway inflammation in asthma and the specific effects
of periostin in mediating eosinophilic forms of asthma.
The role of macrophage also remains unclear, especially
in relation to asthmatic inflammation. Furthermore, the
cell types that mediate various asthmatic conditions are
an important consideration. To date, there are limited
data available regarding the levels and function of peri-
ostin in human asthma and in chronic obstructive pul-
monary disease. Therefore, targeting the actions of
periostin may help elucidate the underlying molecularmechanisms of asthma and may represent a promising
strategy for the development of effective therapeutic
agents for the treatment of asthma.
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